'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' reply

被引:9
作者
Lee, Brian V. [1 ]
Fong, Gary [2 ,4 ,8 ]
Bolaris, Michael [3 ,4 ]
Neely, Michael [5 ,6 ,7 ]
Minejima, Emi [1 ]
Kang, Amy [2 ,4 ,8 ]
Lee, Grace [8 ]
Gong, Cynthia L. [6 ,9 ,10 ]
机构
[1] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90007 USA
[2] Chapman Univ, Sch Pharm, Irvine, CA USA
[3] Harbor UCLA Med Ctr, Div Pediat Infect Dis, Torrance, CA 90509 USA
[4] Lundquist Inst, Dept Pediat, Torrance, CA USA
[5] Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA
[6] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA
[7] Saban Res Inst, Lab Appl Pharmacokinet & Bioinformat, Los Angeles, CA USA
[8] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[9] Childrens Hosp Los Angeles, Div Neonatol, Fetal & Neonatal Inst, Los Angeles, CA 90027 USA
[10] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA
关键词
D O I
10.1016/j.cmi.2021.01.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:929 / 930
页数:2
相关论文
共 5 条
[1]  
[Anonymous], 2018, ANTIMICROB AGENTS CH
[2]  
Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]
[3]   High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity [J].
Hidayat, Levita K. ;
Hsu, Donald I. ;
Quist, Ryan ;
Shriner, Kimberly A. ;
Wong-Beringer, Annie .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) :2138-2144
[4]  
Lee B, 2020, CLIN MICROBIOL INFEC, DOI [10.1016/j.phrs.2020.104743, DOI 10.1016/J.PHRS.2020.104743]
[5]   Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center [J].
Meng, Lina ;
Wong, Tiffany ;
Huang, Sharon ;
Mui, Emily ;
Nguyen, Vinhkhoa ;
Espinosa, Gabriela ;
Desai, Janjri ;
Holubar, Marisa ;
Deresinski, Stan .
PHARMACOTHERAPY, 2019, 39 (04) :433-442